Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study
- PMID: 2684523
- DOI: 10.1159/000417896
Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
